↑Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G(Feb 1996).“Mapping of a susceptibility locus for Crohn's disease on chromosome 16”.Nature379(6568): 821–3.Bibcode:1996Natur.379..821H.doi:10.1038/379821a0.PMID8587604.
↑Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G(Feb 2001).“Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB”.The Journal of Biological Chemistry276(7): 4812–8.doi:10.1074/jbc.M008072200.PMID11087742.
↑Sato H, Williams HR, Spagnolo P, Abdallah A, Ahmad T, Orchard TR, Copley SJ, Desai SR, Wells AU, du Bois RM, Welsh KI(Feb 2010).“CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis.”.Eur Respir J35(2): 324–30.doi:10.1183/09031936.00010209.hdl:11380/983383.PMID19679608.
↑Zhao H, Jia M, Wang Z, Cheng Y, Luo Z, Chen Y, Xu X, Yang S, Tang Y(Jun 2015).“Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis”.Hematology20(5): 254–62.doi:10.1179/1607845414Y.0000000202.PMID25248089.
↑Damiano JS, Stehlik C, Pio F, Godzik A, Reed JC(Jul 2001).“CLAN, a novel human CED-4-like gene”.Genomics75(1–3): 77–83.doi:10.1006/geno.2001.6579.PMID11472070.
Punchard NA(Oct 2001).“Overview: Nod2, cause of, or contributor to, Crohn's disease”.Current Opinion in Investigational Drugs2(10): 1378–81.PMID11890351.
Satsangi J, Morecroft J, Shah NB, Nimmo E(Feb 2003).“Genetics of inflammatory bowel disease: scientific and clinical implications”.Best Practice & Research. Clinical Gastroenterology17(1): 3–18.doi:10.1053/bega.2002.0349.PMID12617879.
Rosenbaum JT, Planck SR, Davey MP, Iwanaga Y, Kurz DE, Martin TM(Oct 2003).“With a mere nod, uveitis enters a new era”.American Journal of Ophthalmology136(4): 729–32.doi:10.1016/S0002-9394(03)00569-5.PMID14516815.
Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N(Oct 2003).“Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation”.Ophthalmology110(10): 2040–4.doi:10.1016/S0161-6420(03)00717-6.PMID14522785.
Girardin SE, Hugot JP, Sansonetti PJ(Dec 2003).“Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing”.Trends in Immunology24(12): 652–8.doi:10.1016/j.it.2003.10.007.PMID14644139.
Newman B, Siminovitch K(Dec 2003).“Inflammatory bowel disease: Crohn's disease and the success of NODern genetics”.Clinical and Investigative Medicine26(6): 303–14.PMID14690304.
Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL(2003).“IBD and genetics: new developments”.Scandinavian Journal of Gastroenterology. Supplement38(239): 63–8.doi:10.1080/00855920310002717.PMID14743885.
Kambe N, Nishikomori R, Kanazawa N(Aug 2005).“The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders”.Journal of Dermatological Science39(2): 71–80.doi:10.1016/j.jdermsci.2005.04.001.PMID15927452.
Newman B, Siminovitch KA(Jul 2005).“Recent advances in the genetics of inflammatory bowel disease”.Current Opinion in Gastroenterology21(4): 401–7.PMID15930978.
Martinon F, Tschopp J(Aug 2005).“NLRs join TLRs as innate sensors of pathogens”.Trends in Immunology26(8): 447–54.doi:10.1016/j.it.2005.06.004.PMID15967716.
Vignal C, Singer E, Peyrin-Biroulet L, Desreumaux P, Chamaillard M(Apr 2007).“How NOD2 mutations predispose to Crohn's disease?”.Microbes and Infection / Institut Pasteur9(5): 658–63.doi:10.1016/j.micinf.2007.01.016.PMID17379562.
Quaglietta L, te Velde A, Staiano A, Troncone R, Hommes DW(May 2007).“Functional consequences of NOD2/CARD15 mutations in Crohn disease”.Journal of Pediatric Gastroenterology and Nutrition44(5): 529–39.doi:10.1097/MPG.0b013e31803815ee.PMID17460484.
van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW(Jun 2007).“CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies”.European Journal of Gastroenterology & Hepatology19(6): 449–59.doi:10.1097/01.meg.0000236887.44214.6a.PMID17489054.